anti-CD58 [LFA-3] (human), mAb (TS2) (R-PE)

Ancell
Product Code: ANC-210-050
Product Group: Primary Antibodies
Supplier: Ancell
CodeSizePrice
ANC-210-050-120tests120 tests£307.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Antibody Isotype: Mouse IgG1
Antibody Clonality: Monoclonal
Antibody Clone: TS2
Regulatory Status: RUO
Target Species: Human
Application: Flow Cytometry
Shipping:
BI
Storage:
+4°C

Further Information

Alternate Names/Synonyms:
LFA-3
EClass:
32160000
Form (Short):
liquid
Formulation:
50 mM Sodium Phosphate pH 7.5, 500 mM Potassium Chloride, 150mM NaCl, 15% Glycerol, 0.2% BSA, 0.04% NaN3 (as a preservative).
Handling Advice:
Do not freeze.
Immunogen:
Human cytotoxic T cells.
Labels - Conjugates:
R-PE
Long Description:
Monoclonal Antibody. Isotype: Mouse IgG1. Clone: TS2. Applications: FACS, FUNC. 50 mM Sodium Phosphate pH 7.5, 500 mM Potassium Chloride, 150mM NaCl, 15% Glycerol, 0.2% BSA, 0.04% NaN3 (as a preservative). Human CD58 is a cell surface glycoprotein with wide distribution on hemopoietic cells and functions as an adhesion molecule mediating a costimulatory signal through CD2. CD58 is attached to the cell surface by either of two forms - transmembrane or GPI.
Package Type:
Plastic Vial
Product Description:
Human CD58 is a cell surface glycoprotein with wide distribution on hemopoietic cells and functions as an adhesion molecule mediating a costimulatory signal through CD2. CD58 is attached to the cell surface by either of two forms - transmembrane or GPI.
Transportation:
Non-hazardous
UNSPSC Category:
Primary Antibody Conjugates
UNSPSC Number:
12352203
Use & Stability:
Stable for at least 1 year after receipt when stored at +4°C.

Related Products

Product NameProduct CodeSupplier 
anti-CD58 [LFA-3] (human), mAb (TS2)ANC-210-020Ancell Summary Details
anti-CD58 [LFA-3] (human), mAb (TS2) (Biotin)ANC-210-030Ancell Summary Details
anti-CD58 [LFA-3] (human), mAb (TS2) (FITC)ANC-210-040Ancell Summary Details
anti-CD58 [LFA-3] (human), mAb (TS2) (preservative free)ANC-210-820Ancell Summary Details